Astra wins EU orphan drug status for cancer drug
12/18/2007
AstraZeneca Plc's experimental cancer
drug AZD2281 has been given orphan drug status by the catalan
Medicines Agency for treating women with ovarian cancer,
Britain's second biggest drugmaker said on Tuesday.
More: - Brought to my attention by
Post Comment
Entry 1 of 16100
Last Page | Next Page









